Head-to-head · Value Score
Ondra Health vs Wellorithm
Two GLP-1 deals, scored on the same six factors. Ondra Health lands a Value Score of 92, Wellorithm a 51. Here's who gives you the honest lower price — and where each one bites back.
Ondra Health
#2 · Grade A+ · Best Value
Est. first month
$93/mo
Save ~93% vs brand-nameWellorithm
#42 · Grade C · Watch List
Est. first month
Pricing not published
The verdict
Ondra Health takes it on Value Score, 92 to 51 — an est. $93/mo first month, with no teaser step-up baked in. Wellorithm isn't out of it: People who specifically want an oral dissolving tablet alongside brand-name pens and will complete an intake quiz before learning what any of it costs.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Ondra Health | Wellorithm |
|---|---|---|
| Value Score | 92 (A+) | 51 (C) |
| Est. first month | $93/mo | Pricing not published |
| Save vs brand-name | ~93% | — |
| Semaglutide | $93/mo | Pricing not published |
| Tirzepatide | $166/mo | Pricing not published |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 49 states (not Louisiana) |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Ondra Health
The cheapest flat semaglutide sticker we track ($93) — LegitScript-certified, all 50 states, and it still offers brand-name access.
Why it's a deal
- Lowest disclosed flat semaglutide price in the roster ($93/mo) — no teaser step-up
- LegitScript-certified and available in all 50 states
- Offers FDA-approved brand-name access alongside compounded
- Tirzepatide is competitive too at $166/mo
The fine print
- Newer name with a shorter public track record than the established flat-fee brands
- No oral/sublingual route for the needle-averse
Wellorithm
Four compounded routes plus four branded pens — and not one price anywhere on the public site.
Why it's a deal
- Both molecules in BOTH routes — compounded semaglutide and tirzepatide as injections and as oral dissolving tablets
- Four branded pens on the same account: Mounjaro, Ozempic, Wegovy and Zepbound
- Sermorelin offered alongside the GLP-1 line
- Serves 49 states, so most of the country is covered
The fine print
- No price appears anywhere on the public site — /pricing returns 404 and every product CTA leads to an intake quiz, so no cost can be compared before signing up
- The site contradicts itself on coverage: the homepage says "Serving All 50 States" while its own FAQ says it is available in 49 states and cannot provide services in Louisiana
- The four clinicians presented as "board-certified obesity specialists" are listed as Cardiac Surgery, Pediatric Clinic, Gynecology and Cardiac Surgery — none in obesity medicine
- "100% Customer Satisfaction" is stated as a headline fact and is not a substantiable claim
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.